MedTrace Logo

French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study

NCT04340466 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1003

Last updated 2025-12-03

No results posted yet for this study

Summary

Since December 2019, a new agent, the SARS-Cov-2 coronavirus has been rapidly spreading from China to other countries causing an international outbreak of respiratory illnesses named COVID-19. In France, the first cases have been reported at the end of January with more than 60000 cases reported since then. A significant proportion (20-30%) of hospitalized COVID-19 patients will be admitted to intensive care unit. However, few data are available for this special population in France.

We conduct a large observational cohort of ICU suspected or proven COVID-19 patients that will enable to describe the initial management of COVID 19 patients admitted to ICU and to identify factors correlated to clinical outcome.

Conditions

  • Pneumonia, Viral
  • Critically Ill
  • Corona Virus Infection

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de Nīmes

    lead OTHER

Principal Investigators

  • CLAIRE ROGER · Centre Hospitalier Universitaire de Nīmes

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-03
Primary Completion
2020-07-03
Completion
2020-07-03

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04340466 on ClinicalTrials.gov